FY2025 Earnings Forecast for Neogen Issued By Zacks Research

Neogen Co. (NASDAQ:NEOG) – Analysts at Zacks Research decreased their FY2025 earnings per share (EPS) estimates for Neogen in a research report issued on Wednesday, February 12th. Zacks Research analyst R. Department now forecasts that the company will earn $0.38 per share for the year, down from their previous estimate of $0.39. The consensus estimate for Neogen’s current full-year earnings is $0.38 per share. Zacks Research also issued estimates for Neogen’s FY2026 earnings at $0.50 EPS and FY2027 earnings at $0.57 EPS.

Neogen (NASDAQ:NEOG) last released its quarterly earnings data on Friday, January 10th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.12. The company had revenue of $231.30 million for the quarter, compared to the consensus estimate of $227.16 million. Neogen had a positive return on equity of 2.89% and a negative net margin of 52.12%. The company’s quarterly revenue was up .7% compared to the same quarter last year. During the same period last year, the business posted $0.11 EPS.

A number of other equities analysts also recently commented on the company. Piper Sandler restated a “neutral” rating and issued a $13.00 price objective (down from $16.50) on shares of Neogen in a report on Tuesday, January 21st. Guggenheim began coverage on Neogen in a report on Thursday, December 19th. They issued a “buy” rating and a $15.00 price objective on the stock.

Neogen Stock Performance

Neogen stock opened at $9.83 on Friday. The stock’s 50-day moving average is $11.78 and its 200-day moving average is $14.21. The company has a market cap of $2.13 billion, a price-to-earnings ratio of -4.49 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 3.77 and a quick ratio of 2.46. Neogen has a 12 month low of $9.70 and a 12 month high of $18.58.

Institutional Investors Weigh In On Neogen

A number of hedge funds have recently bought and sold shares of NEOG. Harbour Investments Inc. acquired a new stake in Neogen during the 4th quarter valued at approximately $27,000. Allspring Global Investments Holdings LLC grew its stake in Neogen by 142.6% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,982 shares of the company’s stock valued at $33,000 after purchasing an additional 1,165 shares in the last quarter. Blue Trust Inc. grew its position in shares of Neogen by 196.7% in the 4th quarter. Blue Trust Inc. now owns 3,368 shares of the company’s stock worth $41,000 after acquiring an additional 2,233 shares in the last quarter. Johnson Financial Group Inc. acquired a new position in shares of Neogen in the 4th quarter worth approximately $43,000. Finally, Covestor Ltd grew its position in shares of Neogen by 41.4% in the 4th quarter. Covestor Ltd now owns 4,103 shares of the company’s stock worth $50,000 after acquiring an additional 1,202 shares in the last quarter. Institutional investors and hedge funds own 96.73% of the company’s stock.

Insider Activity

In other Neogen news, CEO John Edward Adent acquired 23,035 shares of the stock in a transaction on Thursday, January 16th. The stock was purchased at an average price of $11.03 per share, for a total transaction of $254,076.05. Following the purchase, the chief executive officer now directly owns 269,164 shares in the company, valued at $2,968,878.92. This trade represents a 9.36 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO David H. Naemura acquired 14,800 shares of the stock in a transaction on Thursday, January 16th. The shares were acquired at an average price of $11.11 per share, with a total value of $164,428.00. Following the purchase, the chief financial officer now owns 61,434 shares in the company, valued at $682,531.74. This represents a 31.74 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.13% of the company’s stock.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.